Surprise-surprise: Medical Research is finally catching up (a little) to my
patent written in 1996 where I showed the connection between autoimmune
disorders, decreased ATP production, and toxins.Click
here
Catastrophe strikes-again
and again and again.
ATP BOOST will not be available for at least 2 years. The
story
Adenosine triphosphate: established and potential clinical applications.
Agteresch, H. J., P. C. Dagnelie, et al. (1999).
Drugs
58(2): 211-32.
Adenosine 5'-triphosphate (ATP) is a purine nucleotide found in every cell of the human body. In addition to its well established role in cellular metabolism, extracellular ATP and its breakdown product adenosine, exert pronounced effects in a variety of biological processes including neurotransmission, muscle contraction, cardiac function, platelet function, vasodilatation and liver glycogen metabolism. These effects are mediated by both P1 and P2 receptors. A cascade of ectonucleotidases plays a role in the effective regulation of these processes and may also have a protective function by keeping extracellular ATP and adenosine levels within physiological limits.
In recent years several clinical applications of ATP and adenosine have been reported. In anaesthesia, low
dose adenosine reduced neuropathic pain, hyperalgesia and ischaemic pain to a similar degree as morphine or ketamine. Postoperative opioid use was reduced. During surgery, ATP and adenosine have been used to induce hypotension. In patients with haemorrhagic shock, increased survival was observed after ATP treatment. In cardiology, ATP has been shown to be a well tolerated and effective pulmonary vasodilator in patients with pulmonary hypertension. Bolus injections of ATP and adenosine are useful in the diagnosis and treatment of paroxysmal supraventricular tachycardias. Adenosine also allowed highly accurate diagnosis of coronary artery disease. In pulmonology, nucleotides in combination with a sodium channel blocker improved mucociliary clearance from the airways to near normal in patients with
cystic fibrosis. In oncology, there are indications that ATP may inhibit weight loss and tumour growth in patients with advanced lung cancer. There are also indications of potentiating effects of cytostatics and protective effects against radiation tissue damage. Further controlled clinical trials are warranted to determine the full beneficial potential of ATP, adenosine and uridine 5'-triphosphate.
ALL autoimmune disorders
are variations of the same theme.
They are NOT the body attacking itself.
The body is slowly and painfully dying from poisons exceeding its capacity
to detoxify.
The evidence abounds in the scientific literature, but is being ignored
and wrongly interpreted as
"the body attacking itself."
This is the greatest blunder of modern medicine.
There is hope, a future without
pain, and an economical path that can change your life and
put you back in control.
Donna Fezler
The
products and the claims made about products on or through this site have
not been evaluated by the United States Food and Drug Administration and
are not approved to diagnose, treat, cure or prevent disease. The
information, articles, and testimonials provided on this site
are for informational purposes only and are not intended as a substitute
for advice from your physician or other health care professional or any
information contained on or in any product label or packaging. You should
not use the information on this site for diagnosis or treatment of any
health problem or for prescription of any medication or other treatment.
You should consult with a healthcare professional before starting any
diet, exercise or supplementation program, before taking any medication,
or if you have or suspect you might have a health problem.
